alpha 2 Antiplasmin and disseminated intravascular coagulation in liver cirrhosis. 1985

F Marongiu, and A M Mamusa, and G Mameli, and G Mulas, and A Solinas, and L Demelia, and L Contu

Subnormal concentrations of alpha 2 Antiplasmin (alpha 2 AP) in liver cirrhosis may be due to an impaired hepatic synthesis and/or to a fibrinolysis activation in disseminated intravascular coagulation (DIC). In order to clarify this problem, in 26 cirrhotic patients (15 compensated and 11 decompensated) alpha 2 AP plasma activity and plasma Fibrinopeptide A (FPA) were measured. Serum albumin, p-Cholinesterase (p-CHE), Fibrinogen and Fibrinogen Degradation Products (FDP) were also carried out. Our data show that alpha 2 AP and FPA were equally abnormal in compensated and decompensated cirrhosis. The significant negative correlation obtained between alpha 2 AP and FPA as well as the lack of correlation between alpha 2 AP and albumin, alpha 2 AP and p-CHE in both groups suggests that, in our patients, alpha 2 AP decrease may be due to a fibrinolysis activation induced by a DIC which appears chronic since Fibrinogen and FDP were normal. These findings are in agreement with the results obtained in the four subgroups a posteriori selected on the basis of FPA levels: alpha 2 AP in subgroups with high FPA was significantly different from controls while it did not differ in subgroups with normal FPA.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002802 Cholinesterases Acylcholineacylhydrolase,Cholase,Cholinesterase
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D005260 Female Females
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D005344 Fibrinopeptide A Two small peptide chains removed from the N-terminal segment of the alpha chains of fibrinogen by the action of thrombin during the blood coagulation process. Each peptide chain contains 18 amino acid residues. In vivo, fibrinopeptide A is used as a marker to determine the rate of conversion of fibrinogen to fibrin by thrombin. Fibrinopeptides A
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F Marongiu, and A M Mamusa, and G Mameli, and G Mulas, and A Solinas, and L Demelia, and L Contu
July 1992, Journal of hepatology,
F Marongiu, and A M Mamusa, and G Mameli, and G Mulas, and A Solinas, and L Demelia, and L Contu
June 1987, Revista espanola de las enfermedades del aparato digestivo,
F Marongiu, and A M Mamusa, and G Mameli, and G Mulas, and A Solinas, and L Demelia, and L Contu
March 1988, Minerva medica,
F Marongiu, and A M Mamusa, and G Mameli, and G Mulas, and A Solinas, and L Demelia, and L Contu
July 1989, Hepatology (Baltimore, Md.),
F Marongiu, and A M Mamusa, and G Mameli, and G Mulas, and A Solinas, and L Demelia, and L Contu
October 1999, The American journal of gastroenterology,
F Marongiu, and A M Mamusa, and G Mameli, and G Mulas, and A Solinas, and L Demelia, and L Contu
August 1979, La Clinica terapeutica,
F Marongiu, and A M Mamusa, and G Mameli, and G Mulas, and A Solinas, and L Demelia, and L Contu
June 1985, Rinsho byori. The Japanese journal of clinical pathology,
F Marongiu, and A M Mamusa, and G Mameli, and G Mulas, and A Solinas, and L Demelia, and L Contu
March 1973, Polskie Archiwum Medycyny Wewnetrznej,
F Marongiu, and A M Mamusa, and G Mameli, and G Mulas, and A Solinas, and L Demelia, and L Contu
January 1991, La Ricerca in clinica e in laboratorio,
F Marongiu, and A M Mamusa, and G Mameli, and G Mulas, and A Solinas, and L Demelia, and L Contu
January 1972, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
Copied contents to your clipboard!